Thyroid abnormalities in patients treated with lenalidomide for hematological malignancies: Results of a retrospective case review

Management of treatment-related adverse events in patients with multiple myeloma

(2010) María-Victoria Mateos   CANCER TREATMENT REVIEWS

Treatment-related peripheral neuropathy in multiple myeloma: the challenge continues

(2010) Michel Delforge et al.   LANCET ONCOLOGY

Lenalidomide plus dexamethasone versus thalidomide plus dexamethasone in newly diagnosed multiple myeloma: a comparative analysis of 411 patients

(2009) F. Gay et al.   BLOOD

Mechanism of action of lenalidomide in hematological malignancies

(2009) Venumadhav Kotla et al.   Journal of Hematology & Oncology

Hypothyroidism related to tyrosine kinase inhibitors: an emerging toxic effect of targeted therapy

(2009) Francesco Torino et al.   Nature Reviews Clinical Oncology

Practical recommendations on the use of lenalidomide in the management of myelodysplastic syndromes

(2008) Aristoteles Giagounidis et al.   ANNALS OF HEMATOLOGY